The regulatory landscape governing psychoactive substances, synthetic cathinones, and novel research chemicals has evolved dramatically over the past two decades. Across international jurisdictions—including the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland—governments have implemented rigorous legislative controls to curb the distribution and consumption of potentially harmful compounds. […]